“…In addition to the components of translational machinery, RNA-binding proteins are also aberrantly expressed in tumors, including PTB (He et al, 2007), HuR (Lopez de Silanes et al, 2003), KH domain-containing protein, and hnRNPD among others (Gouble et al, 2002), with a direct correlation between abnormal expression of a particular RNA-binding protein and tumor formation (CRD-BP) in breast tissue (Tessier et al, 2004). Furthermore, many RNA-binding proteins have been reported to be direct targets of Akt, including YB-1 (Evdokimova et al, 2006), the tumor suppressor Pdcd4 (Palamarchuk et al, 2005), BRF1 (Benjamin et al, 2006) and KSRP (Gherzi et al, 2006), thus linking the Akt pathway to mRNA silencing, degradation, apoptosis and the Wnt signaling pathway through the promotion of the stabilization of b-catenin mRNA, respectively.…”